Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

Journal of Cerebral Blood Flow and Metabolism

Volumn 20, Issue 4, 2000, Pages 709-717

  Yamada, Masaru ^a   Huang, Zhihong ^a   Dalkara, Turgay ^a,c   Endres, Matthias ^a   Laufs, Ulrich ^b   Waeber, Christian ^a   Huang, Paul L ^a   Liao, James K ^b   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Endothelium; HMG CoA reductase inhibitor; Hyperemia; Nitric oxide; Type III nitric oxide synthase

Indexed keywords

ARGININE; CARBON 14; IOFETAMINE; NITRIC OXIDE SYNTHASE; PHENAZONE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CONTROLLED STUDY; DOPPLER FLOWMETRY; HYPEREMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034006811     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200004000-00008     Document Type: Article

References (14)

1. Arnal J-F, Munzel T, Venema RC, James ML, Bai C-I, Mitch WE, Harrison, DG (1995) Interactions between L-arginine and L-gulutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J Clin Invest 95:2565-2572
2. Ayata C, Ma J, Meng W, Huang PL, Moskowitz MA (1996) L-NA-sensitive rCBF augmentation during vibrissal stimulation in type III nitric oxide synthase mutant mice. J Cereb Blood Flow Metab 16:539-541
3. Büger R, Bode-Büger S, Thiele W, Junker W, Alexander K, Frülich J (1997) Biochemical evidence for impaired nitric oxide synthasis in patients with peripheral arterial occlusive disease. Circulation 95: 2068-2074
4. Betz AL, Iannotti F (1983) Simultaneous determination of regional cerebral blood flow and blood - brain glucose transport kinetics in the gerbil. J Cereb Blood Flow Metab 3:193-199
5. Blauw G, Lagaay A, Smelt A, Westendorp R (1997) Stroke, statins, and cholesterol. A meta-analysis of randomised, placebo-controled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28:946-950
6. Bode-Büger S, Büger R, Creutzig A, Tsikas D, Gutzki F, Alexander K, Frülich, J (1994) L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 87:303-310
7. Bode-Büger S, Büger R, Galland A, Tsikas D, Frülich J (1998) L-arginine-induced vasodilation in healthy humans; pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 46:489-497
8. Byington R, Jukema J, Salonen J, Pitt B, Bruschke A, Hoen H, Furberg C, Mancini G (1995) Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation 92: 2419-2425
9. Cherian L, Chacko G, Goodman JC, Robertson CS (1999) Cerebral hemodynamic effects of phenylephrine and L-arginine after cortical impact injury. Crit Care Med 11:2512-2517
10. Creager M, Gallagher S, XJ G, Coleman S, Dzau V, Cooke J (1992) L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90:1248-1253
11. Dalkara T, Morikawa E, Panahian N, Moskowitz MA (1994) Blood flow-dependent functional recovery in a rat model of focal cerebral ischemia. Am J Physiol 267:H678-H683
12. Delanty N, Vaughan C (1997) Vascular effects of statins in stroke. Stroke 28:2315-2320
13. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA, 95:8880-8885
14. Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z, Moskowitz MA (1997) Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28:1805-1811